These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16735506)

  • 21. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
    Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
    Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
    Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
    Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Hirata Y
    J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of proteasome inhibitors for dihydropyridine-induced gingival overgrowth.
    Lu SL; Chang JH; Huang CF; Chen LS
    Oral Dis; 2020 Apr; 26(3):630-636. PubMed ID: 31856317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.
    Buss H; Dörrie A; Schmitz ML; Hoffmann E; Resch K; Kracht M
    J Biol Chem; 2004 Dec; 279(53):55633-43. PubMed ID: 15489227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
    O'Mahony AM; Montano M; Van Beneden K; Chen LF; Greene WC
    J Biol Chem; 2004 Apr; 279(18):18137-45. PubMed ID: 14963024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma.
    Berenson JR; Ma HM; Vescio R
    Semin Oncol; 2001 Dec; 28(6):626-33. PubMed ID: 11740821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
    Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
    Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.
    Pontoriero M; Fiume G; Vecchio E; de Laurentiis A; Albano F; Iaccino E; Mimmi S; Pisano A; Agosti V; Giovannone E; Altobelli A; Caiazza C; Mallardo M; Scala G; Quinto I
    J Mol Med (Berl); 2019 May; 97(5):675-690. PubMed ID: 30887112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells.
    Tamatani T; Azuma M; Aota K; Yamashita T; Bando T; Sato M
    Cancer Lett; 2001 Oct; 171(2):165-72. PubMed ID: 11520600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Acetyl-L-cysteine and pyrrolidine dithiocarbamate inhibited nuclear factor-kappaB activation in alveolar macrophages by different mechanisms.
    Li YQ; Zhang ZX; Xu YJ; Ni W; Chen SX; Yang Z; Ma D
    Acta Pharmacol Sin; 2006 Mar; 27(3):339-46. PubMed ID: 16490171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C; Bates EE; Arrigo AP
    J Biol Chem; 1998 Feb; 273(6):3180-91. PubMed ID: 9452429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.
    Nomura F; Kawai T; Nakanishi K; Akira S
    Genes Cells; 2000 Mar; 5(3):191-202. PubMed ID: 10759890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide.
    Yang F; Tang E; Guan K; Wang CY
    J Immunol; 2003 Jun; 170(11):5630-5. PubMed ID: 12759443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta.
    Zhao Q; Lee FS
    J Biol Chem; 1999 Mar; 274(13):8355-8. PubMed ID: 10085062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival.
    Koulich E; Nguyen T; Johnson K; Giardina C; D'mello S
    J Neurochem; 2001 Feb; 76(4):1188-98. PubMed ID: 11181838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
    Fuchs O
    Curr Mol Pharmacol; 2010 Nov; 3(3):98-122. PubMed ID: 20594187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome inhibition improves fractionated radiation treatment against non-small cell lung cancer: an antioxidant connection.
    Grimes KR; Daosukho C; Zhao Y; Meigooni A; St Clair W
    Int J Oncol; 2005 Oct; 27(4):1047-52. PubMed ID: 16142322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.